Background: With advances in antiretroviral therapy, most deaths in people with HIV are
now attributable to noncommunicable illnesses, especially cardiovascular disease. We …

Premature CVD among persons with HIV infection is due, in part, to persistent abnormalities
in immune activation and systemic inflammation despite viral suppression. Prevention …

Abstract An Expert Panel convened by the National Lipid Association previously developed
a consensus set of recommendations for the patient-centered management of dyslipidemia …

Background Cardiovascular disease is emerging as a major cause of morbidity and mortality
among patients with HIV. We compared use of national guideline‐recommended …

HIV infection is associated with increased cardiovascular disease (CVD), and increased
rates of myocardial infarction and stroke have been observed in HIV-infected individuals …

Results from several studies have suggested that people with HIV have an increased risk of
cardiovascular disease, especially coronary heart disease, compared with people not …

Lipid abnormalities are prevalent among persons living with HIV infection and contribute to
increasing the risk of cardiovascular events. Antiretroviral therapy (ART) is associated with …

Abstract Background People with HIV (PWH) have increased cardiovascular events,
inflammation, and high-risk coronary atherosclerosis. Statin therapy has been shown to …

Objective: To determine the effect of statins on the progression of subclinical atherosclerosis
in a population of HIV-infected adults on antiretroviral therapy. Design: Double-blind …

Prevention of CVD among the aging population of people with controlled, but chronic, HIV is
vital. Data exploring primary prevention in this context are thus far limited. The Randomized …